logo-loader

Redx Pharma PLC

Receive alerts
Market:
Unlisted (UK)
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

Redx Pharma PLC is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted therapeutics for the treatment of fibrotic disease, cancer and the emerging area of cancer-associated fibrosis.

The company aims to progress its programmes to clinical proof of concept before evaluating options for further development and potential value creation.